Sanofi Dengvaxia Dengue Vaccine from Japan
Dengvaxia live attenuated tetravalent dengue vaccine for seropositive individuals. Measured doses in retail packs classify under HTS 3002.15.00.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Serostatus testing requirement; age/geographic restrictions
• Lyophilized with saline diluent; reconstitution timing
• Live virus containment level 2 lab handling